Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy

Eigenbrodt E, Reinacher M, Scheefers Borchel U, Scheefers H, Friis RR. Double role of pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. In:Critical Reviews in Oncogenesis. Perucho M (Ed.). CRC Press, FL, USA, 91–115 (1992).

Staal GEJ, Rijksen G. Pyruvate kinase in selected human tumors. In:Biochemical and Molecular Aspects of Selected Cancers. Pretlow TG, Pretlow TP (Eds). Academic Press, CA, USA, 313–337 (1991).

Mazurek, 2005, Semin. Cancer Biol., 15, 300, 10.1016/j.semcancer.2005.04.009

Paus, 1996, Tumour Biol., 17, 271, 10.1159/000217989

Mazurek, 1999, J. Cell Physiol., 181, 136, 10.1002/(SICI)1097-4652(199910)181:1<136::AID-JCP14>3.0.CO;2-T

Eigenbrodt, 1980, Trends Pharmacol. Sci, 1, 240, 10.1016/0165-6147(80)90009-7

Mazurek, 1997, J. Bioenerg. Biomembr., 29, 315, 10.1023/A:1022490512705

Eigenbrodt E, Mazurek S, Friis RR. Double role of pyruvate kinase type M2 in the regulation of phosphometabolite pools. In:Cell Growth and Oncogenesis. Bannasch P, Kanduc D, Papa S, Tager JM (Eds). Birkhäuser Verlag, Basel, Germany 15–30 (1998).

Oremek, 2003, Anticancer Res., 23, 1127

Oremek, 2003, Anticancer Res., 23, 1131

Oremek, 2003, Anticancer Res., 23, 1155

McDowell, 2004, Ann. Clin. Biochem., 41, 491, 10.1258/0004563042466712

Hardt, 2000, Anticancer Res., 20, 4965

10.1023/B:DDAS.0000037803.32013.aa

Oehler, 2000, Blood, 95, 1086, 10.1182/blood.V95.3.1086.003k09_1086_1092

Oremek, 1997, Anticancer Res., 17, 3031

Cerwenka, 1999, Anticancer Res., 19, 849

10.1097/mpa.0b013e3180537237

Schulze, 2000, Anticancer Res., 20, 4961

Schneider, 2003, Anticancer Res., 23, 5089

Kim, 2003, Korean J. Gastroenterol., 42, 387

Zhang, 2004, World J. Gastroenterol., 10, 1643, 10.3748/wjg.v10.i11.1643

Kumar, 2007, Eur. J. Gastroenetrol. Hepatol., 19, 265, 10.1097/MEG.0b013e3280102f78

Lamerz R. SCCA (sqamous cell carcinoma antigen). In:Labor und Diagnose. Thomas L (Ed.). TH-Books Verlagsgesellschaft mbH, Frankfurt, Germany 1351–1355 (2005).

Lamerz R. CA 19-9, GICA (gastrointestinal cancer antigen). In:Labor und Diagnose. Thomas L (Ed.). TH-Books Verlagsgesellschaft mbH, Frankfurt, Germany 1302–1305 (2005).

Lamerz R. CA 72-4 (TAG-72). In:Labor und Diagnose. Thomas L (Ed.). TH-Books Verlagsgesellschaft mbH, Frankfurt, Germany 1310–1313 (2005).

Goonetilleke, 2007, Pancreas, 34, 318, 10.1097/MPA.0b013e31802ee9c7

Pinedo, 2005, Gut, 54, A29

Schneider, 2005, Anticancer Res., 25, 1507

Guittet, 2007, Gut, 56, 210, 10.1136/gut.2006.101428

Hardt, 2003, Anticancer Res., 23, 851

Hardt, 2004, Br. J. Cancer, 91, 980, 10.1038/sj.bjc.6602033

Naumann, 2004, Dtsch. Med. Wochenschr., 129, 1806, 10.1055/s-2004-829033

Vogel, 2005, Dtsch. Med. Wochenschr., 130, 872, 10.1055/s-2005-865100

Koss, 2005, Gut, 54, A20

Tonus, 2006, World J. Gastroenterol., 12, 7007, 10.3748/wjg.v12.i43.7007

Shastri, 2006, Int. J. Cancer, 119

Mulder, 2007, Eur. J. Gastroenterol. Hepatol., 19, 878, 10.1097/MEG.0b013e3282cfa49c

Haug, 2007, Br. J. Cancer, 96, 1329, 10.1038/sj.bjc.6603712

Koss, 2008, Colorectal Dis., 10, 244, 10.1111/j.1463-1318.2007.01334.x

Alquist, 1985, N. Engl. J. Med., 312, 1422, 10.1056/NEJM198505303122204

Towler, 1998, Cochrane Database Syst. Rev., 2, CD001216

Macrae, 1982, Gastroenterology, 82, 891, 10.1016/S0016-5085(82)80252-7

Mandel, 1993, N. Engl. J. Med., 328, 1365, 10.1056/NEJM199305133281901

Mandel, 1999, J. Natl Cancer Inst., 91, 434, 10.1093/jnci/91.5.434

Kronborg, 1996, Lancet, 348, 1467, 10.1016/S0140-6736(96)03430-7

Jorgensen, 2002, Gut, 50, 29, 10.1136/gut.50.1.29

Hardcastle, 1996, Lancet, 348, 1472, 10.1016/S0140-6736(96)03386-7

Mandel, 2000, N. Engl. J. Med., 343, 1603, 10.1056/NEJM200011303432203

Davies, 2005, Nat. Rev. Cancer, 5, 199, 10.1038/nrc1569